Edition:
India

Zogenix Inc (ZGNX.OQ)

ZGNX.OQ on NASDAQ Stock Exchange Global Market

59.20USD
18 Jul 2018
Change (% chg)

$-1.90 (-3.11%)
Prev Close
$61.10
Open
$60.80
Day's High
$60.85
Day's Low
$59.10
Volume
201,104
Avg. Vol
157,080
52-wk High
$62.75
52-wk Low
$10.05

Select another date:

Thu, Jul 12 2018

Photo

Zogenix's seizure drug clears late-stage trial, shares soar

Zogenix Inc said on Thursday its drug to treat a rare form of childhood epilepsy reduced convulsive seizures in a second late-stage trial, sending the drug developer's shares up as much as 26 percent.

UPDATE 2-Zogenix's seizure drug clears late-stage trial, shares soar

July 12 Zogenix Inc said on Thursday its drug to treat a rare form of childhood epilepsy reduced convulsive seizures in a second late-stage trial, sending the drug developer's shares up as much as 26 percent.

Zogenix's treatment for rare epilepsy meets advanced study goal

July 12 Zogenix Inc said on Thursday its drug to treat Dravet syndrome, a rare form of epilepsy, met the main goal of a late-stage trial.

BRIEF-Zogenix Q1 Loss Per Share $0.87

* ZOGENIX PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER FINANCIAL RESULTS

BRIEF-Zogenix Inc Q4 Loss Per Share $1.17

* ZOGENIX PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

BRIEF-Zogenix Completes Enrollment In Second ZX008 Phase 3 Clinical Trial In Dravet Syndrome

* ZOGENIX COMPLETES ENROLLMENT IN SECOND ZX008 PHASE 3 CLINICAL TRIAL IN DRAVET SYNDROME

Select another date: